TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 that is in Phase I of clinical trial for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation
Read MoreTurning Point Brands, Inc. (TPB) Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes adult consumer products. Philip Morris International Inc. (PM) Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine […]
Read MoreNVIDIA Corporation (NVDA) NVIDIA Corporation provides graphics, and compute and networking solutions in the United States, Taiwan, China, and internationally. FTAI Aviation Ltd. (FTAI) FTAI Aviation Ltd. owns and acquires infrastructure and related equipment for the transportation of goods and people worldwide. It operates through two segments, Aviation Leasing and Aerospace Products. Adtalem Global Education […]
Read More